Pfizer Medical Information

Health Care Professionals Log In

  Questions?

Submit Medical Question»

This site is intended for U.S. Health Care Professionals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 

Oncology News features editorially independent news content provided by MDLinx. Pfizer does not influence and is not involved with the selection of content in this section.

  		• Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
    Aft RL et al. ZOL administered with chemotherapy may improve DFS and OS in a subset of BC patients..    		Fri, 25 May 2012

  		• Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients
    Felix AS et al. These IHC data show that tumour and stromal bFGF expression have opposite associat..    		Fri, 25 May 2012

  		• KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
    Kawamoto Y et al. Because the mutational statuses of predictive biomarker genes were not altered b..    		Fri, 25 May 2012

  		• Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer
    Mochiki E et al. S-1+paclitaxel was suggested to be a feasible and effective non-platinum-based re..    		Fri, 25 May 2012

  		• High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma
    Du J et al. A high preoperative plasma fibrinogen level is an independent predictor of distant met..    		Fri, 25 May 2012

    Click here to view more articles.

    The article you selected will open in a new window, and you will be redirected to the publisher's web site. To return to Pfizer for Oncology Professionals, close the new window.